Description http://www.worldconferencecalendar.com/index.php?option=com_conference Fri, 18 May 2012 00:00:27 +0100 FeedCreator 1.7.2 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3362/Itemid,0/ Being up-to-date with current requirements and understanding individual authority interpretation of guidelines is critical for successful product registration. The challenge in Asia is the frequency of changing regulations and increasing time-lag for regulatory approval – factors which can significantly impact on your time to market and bottom line. IBC’s Pharmaceutical Regulatory Asia Summit is the longest standing event of its kind in the region. In our 5 th year, we are emphasizing collaborations between industry and authority to expedite the approval of safe and effective drugs. In this event you will not be presented with a series of regulatory checklists that you can find online. What you will gain is:  Real-life industry experience in dealing with particular authorities  More opportunity to engage in Q&A discussions with regulatory authorities and industry experts  The chance to ask questions that you want answered to expedite your own approval process What’s New for 2012  More speakers than ever before: Learn from and network with 30+ regulators & regulatory professionals  First-time! EU Regulator discussing latest updates and future impact in Asia  New Pfizer case-study: Seeking operational excellence in delivering global submissions  First-time! Lessons learned from implementing a new streamlined submission process at the TGA  New formats allowing for more interaction, collaboration and discussion: Meet the Regulator Q&A, In-depth China & Key Growth Markets round-tables, strategy sessions in the Discussion Den - Health and Medicine Thu, 17 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3361/Itemid,0/ Overview: This course will present, in one place, the regulations and guidelines that apply to early phase products. In some cases these will not be regulations, but needs that, if met, will increase the efficiency of activities as a product proceeds through the development process. The course will present these items in the order of product development from the point of R & D activities to the completion of Phase 2 clinical trials. Why should you attend: Any pharmaceutical worker who must deal with products both in early and latter phases of development should attend this course in order to be aware of the regulatory requirements that will affect operations dealing with these products. The modifications to the GMPs for early phase products have modified the GMPs in such a way as to reduce requirements to allow more efficient work. At the same time some of the things that may appear to have changed, have not, and the pharmaceutical worker should be aware of this. Seminar Content: India Seminar 2012 at Mumbai: Day 1 - 18th June 2012 • Lecture 1: Very Early Stages • Lecture 2: What the ICH Q8 Annex covers • Lecture 3: GLP requirements • Lecture 4: GLP-based Animal Studies Day 2 - 19th June 2012 • Lecture 5: Early Pre-IND Studies • Lecture 6: The Preclinical/Clinical Interface • Lecture 7: The Animal Rule and Orphan Drugs • Lecture 8: Pediatric considerations Day 3 - 20th June 2012 • Lecture 9: GMPs for Phase 1 Products. Part 1 • Lecture 10: GMPs for Phase 1 Products. Part 2 • Lecture 11: Phase 2 Products Who Will Benefit • Presidents • Vice Presidents of Technical Departments • Managers • Directors • Regulatory Associates and Analysts • Quality • Regulatory • Research • Development Group Heads About Speaker: Dr Steven S. Kuwahara currently heads GXP BioTechnology . He is an experienced analytical biochemist who has applied his knowledge to the quality control area of pharmaceuticals. His work has dealt with all aspects of GMP and GLP in relation to drugs and biopharmaceuticals. He has worked with small molecules, proteins, cells, gene therapy vectors and nutritional supplements. Dr. Kuwahara has written many papers and book chapters, and serves on the editorial advisory boards of BioPharm, BioQuality, Journal of Validation Technology, and Journal of GXP Compliance. For the last of these, he also writes a column called “The GLP Forum.” He has held certifications such as CQA, CQT, and CQE from the American Society of Quality, and was certified RAC by the Regulatory Affairs Professionals Society. DATE AND VENUE: 18th, 19th and 20th June, 2012 at Mumbai Conference Timings: 9:00 am - 6:00 pm Intercontinental The LaLit, Sahar Airport Road, Andheri East Mumbai - 400059 INDIA Price – Rs18000 Contact Information: Event Coordinator Toll free: 1800 425 9409 Phone number: +91 80-3221-3341 / +91 80-3247-3696 /+91 80-3221-3329. FAX : +91 80-2642-1483 Email: customersupport@globalcompliancepanel.com Website: http://www.globalcompliancepanel.com GlobalCompliancePanel NetZealous Services India Pvt. Ltd. 4th Floor, A, Block, Brigade Software Park, Banashankari 2nd stage, Bangalore-560070. INDIA. Link: http://bit.ly/LVLL7l - Health and Medicine Thu, 17 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3360/Itemid,0/ In the current era of qualitative communication, the present virtual space is intended to be a meeting point of all those who freely wish to boost and perfect the set of strategies and techniques to improve the human-computer interaction, tourism and cultural heritage. The main goal is to facilitate communicability and make the fruition of the new technologies more pleasant. Our effort focuses on finding the common denominator between the human-computer interaction, cultural heritage and the global village. That is, we address all those who are currently working to increase the quality of life of the human beings through the new technologies and all their derivations, wanting to know the last advances in the factual and formal sciences and that this international workshop can serve as a meeting point to boost the current and future lines of research of the investigators belonging to the university, governmental bodies and the enterprises and industries of the private sector. All contributions should be of high originality, quality, clarity, significance and impact. Papers, demos and doctoral consortium related to Human-Computer Interaction, Tourism, Cultural Heritage, Quality Design, Communicability, Ubiquitous Computing and other Computational Areas are solicited on, but not limited to: :: Advances in Hypermedia Systems :: Audio-visual Communication and Multimedia :: Blended Learning :: Character for Guided Tour and Behaviour Computer Animation :: Cognitive Models and Critical Design :: Communicability :: Computer Graphics and Computer Animation :: Computer Aided Education (CAE) :: Computer Arts :: Computer-Aided Design (CAD) :: Cross-Cultural and Internationalization of Design :: Database Application Development :: Development of Research and Education in Heritage Conservation :: Digital Divide :: Distributed Computing and Networking :: E-book :: E-commerce :: E-culture :: E-government :: Eco-design :: Electronic Presentation, Publishing, and Digital Libraries :: Embedded Computing :: Emerging Technologies :: Emotional Design :: Ergonomics :: Human Factors and Computer Science :: Human-Computer Interaction :: Image Processing: Color Correction, Image Warping, Morphing and Painting :: Immersive Multimedia, Mixed Reality and Virtual Reality :: Indexing and Search Technique for Hypermedia Databases :: Information Technology and Communication for Regional Development :: Integration of Artificial Intelligence with other Technologies for the Tourism :: Interactive Systems for Cultural and Ecological Heritage :: Journalism On-line: Discursive Analysis :: Knowledge-Based Simulation :: Marketing, Tourism and Geospatial Information Systems :: Methodologies for Heuristic Evaluation of the Quality :: Microinformatics for Conservation and Promotion of Cultural Heritage :: Mobile Network Security :: Multimedia for Assessing Tourist Demand in World Heritage Sites :: Online Museum :: Open Source Software :: Photography and Illustration Digital :: Preservation and Image Restoration of Digital Culture :: Quality Attributes and Metrics for Interactive Systems :: Reusability of the Current Digital Archiving Solutions :: Role of Local Community and ICTs in Cultural Heritage Management :: Semiotics for Interactive Design :: Software Engineering :: Software Testing, Evaluation and Analysis Technologies :: Speech and Natural Language Interfaces :: Storytelling and Augmented Realities :: Technological and Economical Valuation of Natural and Cultural Heritage Resources :: Telecommunications and Marketing Models in the Museum as Distributed Network :: Teleworking :: Tourism Technology Management :: Ubiquitous Computing :: Usability Engineering :: Video games :: Virtual Architecture and Hypergraphics :: Virtual Campus and Distance Education :: Virtual Travel Agencies :: Visitor and ICTs Impact Management for World Heritage Sites :: Visual Effects and Cinema Digital :: Visualization Tools and Systems for Simulation and Modeling :: Web 2.0 and Web 3.0 :: Web TV, 3D TV and Stereo Visualization :: Wireless and Mobile Computer Science Best regards, Francisco V. Cipolla Ficarra (Chair - coordinator) & Doris Edison and Mary Brie (International Secretariat) === Workshop registration fee includes: - All authors can present more than one paper with only one registration (maximum two papers). - Conference proceedings (on CD or DVD) - Cultural experience - Discounts in official hotels - Entrance in the exhibition area - Participation in all open session - Refreshment breaks - Three local excursions / trips - Computer Science and Internet Thu, 17 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3359/Itemid,0/ The CAFE Standards’ benchmarks are fast approaching, and the need to create lighter vehicles to aid in reducing emissions and increase fuel efficiency is at an all time high. The 5th Advanced Lightweight Materials Summit has been designed to provide automobile manufactures and suppliers the latest advances and materials selection strategies to promote lighter weight, higher performing, fuel efficient vehicles without sacrificing safety or performance. This program will feature the latest breakthroughs in lightweight materials and cutting-edge adaptive applications. Join us, August 27-28th in Detroit, MI and explore strategies to accelerate the transition from prototyping to full scale manufacturing. Learn from OEMs, Tier 1 suppliers, universities, and research institutions tangible, cost-effective strategies in lightweighting. - Engineering and Technology Wed, 16 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3358/Itemid,0/ Strategic Development to Enhance Production, Reduce Costs and get your Product to Market Ahead of your Competition. The most comprehensive event focusing on the innovations in Fuel Efficient Engine technologies from leading international OEMs. In the coming years, automotive manufacturers face increasingly strict emissions and fuel efficiency requirements. There are many new technologies out there; IQPC brings you a conference that brings together industry experts to assess the most commercially viable and the most cost effective technologies and methods available to achieve this. In spite of the strong focus on electric and hybrid vehicles development, modern combustion engines are still the dominating technology – and will be for quite some time. There is still considerable development potential, both in gasoline, diesel and hybrid power-train. - Engineering and Technology Wed, 16 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3357/Itemid,0/ IMMUNO2013 is a leading immunosuppression conference that provides researchers and practitioners with the latest developments in the fields of Immunosuppression, Immunomodulation and Immunotherapy. The conference will facilitate networking, the exchange of knowledge, and opportunities to learn from world experts. - Health and Medicine Wed, 16 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3356/Itemid,0/ The 10th International Congress on Coronary Artery Disease (ICCAD 2013) is a CME-accredited forum aimed at researchers and clinical practitioners in cardiovascular disease. ICCAD gatherings have developed a well-earned reputation for providing participants with a platform to exchange ideas relating to coronary artery disease. - Health and Medicine Wed, 16 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3355/Itemid,0/ Join world-renowned experts for the most advanced research and techniques in gynecologic cancer patient care. - Health and Medicine Wed, 16 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3354/Itemid,0/ Building on the success of the 2011 Corporate IT Exchange, we are delighted to announce the next Corporate IT Exchange will take place in Germany in September 2012. The Corporate IT Exchange is an exclusive networking forum for European C-Level IT executives looking to effectively align their resources and processes with business strategy. Cost reduction, energy efficiency, consumerisation of IT and optimisation of innovative, efficient and flexible infrastructures are currently the biggest challenges for CIOs. Management boards expect cost cutting and more efficient working processes. The Corporate IT Exchange unites IT leaders in a unique format so they can discuss how IT can become an independent business division, evaluate business models that optimise Corporate IT, and analyse how their department can become more sustainable and strategic. This forum enables you to network, debate and discover innovative solutions through a series of conference sessions, interactive roundtable discussions and pre-arranged, one-on-one meetings with a range of solution providers. Confirmed Speakers include: • Afzal Ballim, CIO, The International Committee of the Red Cross (ICRC) Professor Christopher • Rentrop, HTWG Konstanz • Jeremy Vincent, CIO, Jaguar & Land Rover • Olaf Riedel, Partner, Advisory Services, Ernst & Young • Rene Aarts, IS Hub Director (CIO DACH & Slovenia), Danone • Yves Danneels, CIO, Credit Agricole/Crelan To request the attendee list email: exchangeinfo@iqpc.com, or call: +44 (0) 207 368 9404. You can also email exchangeinfo@iqpc.com, or call: +44 (0) 207 368 9404 for more information on solution provider opportunities or to request your delegate invitation. Website: www.corporateitexchange.com - Computer Science and Internet Wed, 16 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3353/Itemid,0/ In 2012, General Counsel are being pulled in a number of directions. Regulatory enforcement in Europe and internationally is intensifying, whilst pressure from the Board to do more with less is increasing. Heads of legal are looking for new ways to drive efficiencies; most are requiring more value from external counsel but in some cases this is sabotaging well-developed relationships. Global company growth is still impacting on legal strategy and compliance decisions and new regulations, such as the proposed EU data privacy changes, are adding an extra burden to an already stretched legal department. The 7th Corporate Counsel Exchange offers a perfect setting for senior legal professionals to network, debate and develop effective business strategies. This exclusive, invitation only event tackles the challenges that heads of legal face today and offers new solutions through a series of case studies, panel discussions, interactive roundtables and pre-arranged, one-on-one meetings with a range of solution providers. Confirmed Speakers Include: • Hans Albers, Senior Director Legal Affairs and Associate General Counsel EMEA, Juniper Networks • Charles Barber, Director - Global Trade Compliance – EMEA, Tyco International • Torsten Bartsch, Head of EAME Commercial Legal Services, Caterpillar • Martin Clausen, General Counsel, Maersk Line • Martin Fischer, General Counsel Europe, Celanese GmbH • Merja Karhapaa, Chief Legal Officer, Sanoma Group • Claus-Dieter Ulmer, Group Data Protection Officer, Deutsche Telekom • Charles Barber, Director - Global Trade Compliance – EMEA, Tyco International • Monica Risam, General Counsel, Aviva Europe • Duncan Perry, Global General Counsel, Barclays Wealth To request the attendee list email: exchangeinfo@iqpc.com, or call: +44 (0) 207 368 9404. You can also email exchangeinfo@iqpc.com, or call: +44 (0) 207 368 9404 for more information on solution provider opportunities or to request your delegate invitation. Website: www.corporatecounselexchange.co.uk - Law Wed, 16 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3352/Itemid,0/ 9th Corporate Counsel Exchange June 18 – 20, 2012 Sawgrass Marriott, Florida, USA The role of General Counsel has evolved rapidly, becoming more prominent and complex over the past few years. General Counsels need to address top-level business issues as well as provide counsel on non-legal matters whilst accurately assessing and managing global legal and compliance risks. Increasing regulation in both a national and international context, and inconsistency of legislation in different jurisdictions, impose great challenges for General Counsels and their legal teams. The 9th Corporate Counsel Exchange offers a perfect setting for senior legal professionals to network, debate and develop effective business strategies. This exclusive, invitation only event tackles the challenges that face heads of legal today and helps find solutions through a series of conference sessions, roundtable discussions and pre-arranged, one-on-one meetings with a range of solution providers. Our past attendees say it best: "A great opportunity to share with other counsel ways to address risk areas and identify solutions" - Director, Regulatory Law, Winn-Dixie "Best content and organization I have seen in a course in 20 years" - Legal Counsel, Quicksilver Resources Canada Inc. "The program is comprehensive, the topics are relevant, the speakers are respected and on point, and the staff attentive" - Chief Corporate Compliance Officer & Counsel, Skanska To request the list of attendees, or for other information email: exchangeinfo@iqpc.com or call: +44(0)207 368 9404 Website: www.corporatecounselexchange.com - Law Wed, 16 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3351/Itemid,0/ Dear Sir or Madam, As Karlshochschule International University, we are organizing the 2nd International Conference on Narrative & Innovation “Rethinking Diversity”. The conference will take place at our university campus which is located in Karlsruhe, Southwest Germany, on 20th and 21st of September, 2012. The conference will be dedicated to “Diversity”: In the growing dynamism of the globalized world, change in societies, markets and organizations is becoming more and more crucial. Not only from a competitive point of view is the recognition of diversity more valuable, the better its complexity is comprehended. The sub-themes of the conference are following: • Cultural diversity in organizations • Ageing in a diverse workforce and society • Diversity and urban governance • Diversity and innovation We have confirmed six keynote speakers for the conference Prof. Juhani Ilmarinen from Finland, Prof. Vincent J. Roscigno from Ohio State University, USA, Prof. Nikola Hale from Furtwangen University, Germany, Prof. Renate Ortlieb from University of Graz, Austria, Prof. Alois Moosmüller from Ludwig Maximilians University, Germany and Prof. Alexandra Kalev from Tel Aviv University, Israel. The conference will include open space discussions, panels and presentations where our participants can contribute and present their ideas and way of thinking regarding Diversity. - Business and Economics Tue, 15 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3350/Itemid,0/ Speaker panel: • HR Director EMEA, LinkedIn • Global Head of Talent Management, ING Bank • HR Director, Talent & Leadership Development, Nokia • Director, Talent and Reward EMEA, The Walt Disney Company • Global Director of Assessment Services, Hertz • Group Head of Talent Management and Learning, Zurich Financial Services • Global Head of Talent & Reward, Bombardier Transportation • Head of Talent Acquisition, World Economic Forum • Author of "Evaluating the ROI from Learning" • Group Head of Talent, Royal Bank of Scotland - RBS Attend and : • Recognise the importance of Redefining & Rethinking Visions • Improve on Talent Program Measurement • Challenge your current systems with Industry Best Practices • Gain insights into the latest Trends in TM • Listen to Case Studies from peers that have achieved Real and Measurable Results • And much more - Business and Economics Tue, 15 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3349/Itemid,0/ Speaker panel: • HR Director EMEA, LinkedIn • Global Head of Talent Management, ING Bank • HR Director, Talent & Leadership Development, Nokia • Director, Talent and Reward EMEA, The Walt Disney Company • Global Director of Assessment Services, Hertz • Group Head of Talent Management and Learning, Zurich Financial Services • Global Head of Talent & Reward, Bombardier Transportation • Head of Talent Acquisition, World Economic Forum • Author of "Evaluating the ROI from Learning" • Group Head of Talent, Royal Bank of Scotland - RBS Attend and : • Recognise the importance of Redefining & Rethinking Visions • Improve on Talent Program Measurement • Challenge your current systems with Industry Best Practices • Gain insights into the latest Trends in TM • Listen to Case Studies from peers that have achieved Real and Measurable Results • And much more - Business and Economics Tue, 15 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3348/Itemid,0/ This 90-minute webinar will focus on the critical steps in starting up a new cleanroom operation and releasing it for manufacturing. It includes a case study-based approach to dealing with excursion events and establishing control of the cleanroom after a worst case event. Why Should You Attend:- This webinar will focus on starting up a new cleanroom operation covering from utilities to environmental monitoring. Routine cleaning and disinfection will also be addressed. Addressing contamination and bringing up the cleanroom after a worst case even will be discussed. Cases studies on bringing up the site after a worst case event will be discussed in detail. Excursion investigations will also be discussed and troubleshooting parameters and suggestions will be discussed. Areas Covered in the Seminar:- - The critical steps needed to release the room for manufacturing will be discussed. - Routine Cleaning and Disinfection Strategies will be covered as well as the latest in equipment and application. - Establishing control of the cleanroom after a worst case event. - Excursion events will be discussed and case studies will be covered regarding excursion events. - Physical and Life Sciences Tue, 15 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3347/Itemid,0/ This webinar will provide an introduction to FDA’s regulation of veterinary regenerative medicine and highlight the regulatory requirements that a biotech company needs to satisfy to commercialize a stem cell or other complex biotech product for animal use in the U.S. Why Should You Attend:- The rapid development of cell-based and related biological therapies for use in veterinary medicine has provided exciting new options for the safe and effective treatment of common veterinary diseases and conditions such as osteoarthritis, tendon strain injuries, suspensory desmitis, congestive heart failure and other commonly diagnosed diseases and injuries. FDA’s Center for Veterinary Medicine (“CVM”) asserts primary and exclusive regulatory jurisdiction over veterinary regenerative products and their future commercialization in the U.S. Under CVM’s proposed regulatory approach, a veterinary regenerative product exceeding a hypothetical veterinary equivalent standard will be treated as a drug requiring FDA review and approval prior to marketing and sale. - Physical and Life Sciences Tue, 15 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3346/Itemid,0/ This 90-minute webinar will discuss the new FDA "Global Engagement" Initiative for new areas for heightened CGMP compliance from U. S. FDA-regulated companies and their global partners. It will cover areas for increased awareness, focus, and remediation, and the approaches that are now mandated. Why Should You Attend:- The last two years have seen major initiatives at the FDA; as well as prominent drug and device failures over cGMP issues, resulting in recalls, lawsuits, class action lawsuits, and even possible criminal prosecution. The FDA sees globalization as a growing reality, and potential contributor of major regulatory issues: the supply chain, counterfeiting, clinical trials, other global outsourcing actions; by global / multinational corporations. A new paradigm for FDA guidance and strengthened enforcement is called for. Areas Covered in the Seminar:- - The U.S. FDA's New Global Engagement Initiatives. - Recent global industry trends, bad and good. - Major foreseeable problem areas. - How the FDA initiatives impact regulated industries. - Immediate actions to take. - Long-term correction / preventive action of FDA-defined problem areas. - Health and Medicine Tue, 15 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3345/Itemid,0/ This 90-minute webinar will review the 21 basic elements that need to be addressed in the traditional 510(k) submission, as required by the FDA. Why Should You Attend:- The U.S. FDA mandates that the traditional 510(k) submission address 21 basic requirements. The "Special" and "Abbreviated" 510(k)s must also address them, but in different ways. In addition, the FDA Task Force has identified several problem areas with the existing medical device 510(k) process, leading to the growing push by the Agency to strengthen the 510(k) process. What can companies do proactively to address these concerns and better ensure a smoother review process? Areas Covered in the Seminar:- - The Three Types of 510(k)s and Their Uses. - The 21 Required Elements in the 510(k), and How Documented. - Finding, Proving and Documenting Substantial Equivalence. - Addressing Product "With-" or "As-software" Issues. - The "Statement" or The "Summary". - Health and Medicine Tue, 15 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3344/Itemid,0/ This Project Management training for Auditors will help you understand how to apply project management principles to auditing to ensure efficient and effective quality assurance of drug development. Why Should You Attend:- Auditing is essential to ensuring quality assurance of drug development. Each audit has a degree of complexity which needs effective project management. With ever increasing pressures to complete the audit promptly and to the appropriate quality standard, the effective use of project management can provide essential tools and techniques to achieve this. Indeed effective project management can be a key factor to successful completion of efficient auditing. This presentation will provide you with an excellent understanding of project management skills, to apply to auditing in all GXP areas. You will be provided with an integrated project tool kit which can easily be used with your existing or future project management tools used for auditing. This tool kit has been used to significantly improve the successful completion of auditing on time to the right quality standard in many pharmaceutical organisations. The presentation will show you how to use these project management skills to gain the most benefit from them in your auditing activities. - Physical and Life Sciences Tue, 15 May 2012 00:00:00 +0100 http://www.worldconferencecalendar.com/component/option,com_conference/page,show_ad/catid,0/adid,3343/Itemid,0/ This 90-minute webinar will help you understand what the true costs are for completing a clinical study and the unanticipated costs that may arise. You will learn about costs that a sponsor must include in a budget and costs that a site bears in the conduct of clinical research. Why Should You Attend:- Determining an appropriate clinical trial budget to ensure a study can be completed is challenging for both sites and sponsors. Whether you are new to clinical research, or have years of experience, there are 3 areas of expertise you may not have mastered - understanding and outlining costs, negotiating budgets, and complying with criteria (Medicare provisions for determining Qualifying Trials and Routine Care). If not, you may be a site that is underwriting sponsors costs, or you may be a sponsor that is overpaying site costs, and both sites and sponsors may be incorrectly submitting non-qualifying costs to insurers. Learning Objectives:- At the end of this webinar, participants will understand categories of study costs and be able to identity costs that sponsors are expected to cover. Areas Covered in the Seminar:- - Start-Up Costs. - Fixed Costs. - Variable Costs. - Hidden Costs. - Overhead. - Education Tue, 15 May 2012 00:00:00 +0100